Great West Life Assurance CO Allogene Therapeutics, Inc. Transaction History

Great West Life Assurance CO

$58 Billion
Q4 2024

A detailed history of Great West Life Assurance CO transactions in Allogene Therapeutics, Inc. stock. As of the latest transaction made, Great West Life Assurance CO holds 20,425 shares of ALLO stock, worth $39,828. This represents 0.0% of its overall portfolio holdings.

Number of Shares

20,425

Previous 20,184 1.19%

Holding current value

$39,828

Previous $57,000 22.81%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$1.84 - $3.22 $443 - $776	241 Added 1.19%	20,425 $44,000
Q3 2024 Nov 13, 2024	SELL	$2.08 - $3.5 $8,128 - $13,678	-3,908 Reduced 16.22%	20,184 $57,000
Q2 2024 Aug 12, 2024	BUY	$2.23 - $4.38 $14,142 - $27,777	6,342 Added 35.73%	24,092 $56,000
Q1 2024 May 13, 2024	BUY	$2.92 - $5.63 $23,833 - $45,952	8,162 Added 85.13%	17,750 $79,000
Q4 2023 Feb 13, 2024	SELL	$2.28 - $3.5 $5,889 - $9,040	-2,583 Reduced 21.22%	9,588 $31,000
Q2 2023 Aug 10, 2023	BUY	$4.53 - $6.74 $15,148 - $22,538	3,344 Added 37.88%	12,171 $61,000
Q1 2023 May 12, 2023	BUY	$4.92 - $8.21 $8,983 - $14,991	1,826 Added 26.08%	8,827 $43,000
Q4 2022 Feb 10, 2023	BUY	$5.62 - $11.11 $4,366 - $8,632	777 Added 12.48%	7,001 $44,000
Q3 2022 Nov 01, 2022	BUY	$10.32 - $17.28 $64,231 - $107,550	6,224 New	6,224 $67,000
Q2 2022 Aug 09, 2022	BUY	$6.78 - $12.28 $3,410 - $6,176	503 Added 9.6%	5,740 $66,000
Q1 2022 May 12, 2022	BUY	$7.65 - $15.29 $3,442 - $6,880	450 Added 9.4%	5,237 $50,000
Q4 2021 Feb 14, 2022	BUY	$13.13 - $24.52 $5,764 - $10,764	439 Added 10.1%	4,787 $72,000
Q2 2021 Aug 11, 2021	SELL	$23.49 - $35.8 $4,721 - $7,195	-201 Reduced 4.42%	4,348 $113,000
Q1 2021 May 17, 2021	BUY	$25.79 - $39.02 $24,113 - $36,483	935 Added 25.87%	4,549 $159,000
Q3 2020 Nov 17, 2020	BUY	$32.38 - $44.96 $117,021 - $162,485	3,614 New	3,614 $136,000
Q3 2020 Nov 13, 2020	SELL	$32.38 - $44.96 $117,021 - $162,485	-3,614 Closed	0 $0
Q2 2020 Aug 17, 2020	BUY	$18.39 - $54.04 $36,540 - $107,377	1,987 Added 122.13%	3,614 $154,000
Q4 2019 Feb 11, 2020	BUY	$24.82 - $31.4 $40,382 - $51,087	1,627 New	1,627 $42,000
Q3 2019 Oct 25, 2019	SELL	$26.11 - $32.99 $80,079 - $101,180	-3,067 Closed	0 $0
Q2 2019 Jul 31, 2019	BUY	$25.56 - $31.09 $78,392 - $95,353	3,067 New	3,067 $0

Others Institutions Holding ALLO

# of Institutions

177

Shares Held

139M

Call Options Held

75.8K

Put Options Held

52.8K

View Full List

About Allogene Therapeutics, Inc.

Ticker ALLO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 143,807,008
Market Cap $280M
Description
Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...

More about ALLO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

News

Stay updated on Great West Life Assurance CO with notifications on news.

Account

Great West Life Assurance CO Allogene Therapeutics, Inc. Transaction History